Register now to our Newsletter

* indicates required







Our latest news

New Endoscopy Imaging Platforms

TransCure presents its new Endoscopy Imaging platform.

2019 achievements and new objectives in 2020

TransCure bioServices shares with you its major achievements in 2019 and its objectives 2020.

Human cytokine boosts available for enhanced differentiation/boosting of myeloid – NK – dendritic cells in hu-mouse models

Transient Human Cytokine Boost TransCure bioServices is sharing human immune cell boosting data. Transient boost increases the number of NK, Myeloid and Dendritic cells and their states of activation in the Advanced Human Immune System Mouse Models Diseases. Transient...
The talk about us in the press: LaBiotech

They talk about us in Labiotech – Human liver disease mouse models

Find more about how TransCure improves Liver Diseases research with its humanized mouse model.
Promising HIV Cure demonstrated using CD34+ hu-mouse

HIV publication relevance

Demonstration of viral clearance targeting latent infectious reservoirs in HIV-1 infected CD34+ human immune system mice treated with LASER ART and CRISPR-Cas9 is available.

New IHC platform is now available at TransCure

TransCure presents its new IHC platform.

Three employees join TransCure bioServices team.

TransCure bioServices hires 3 new employees.
BMS and Viiv published efficacy data using TransCure’s full human immune system hu-mouse models

TransCure bioServices involved in BMS and Viiv results

BMS and Viiv published in vivo efficacy data on a new anti-HIV treatment using our Advanced Human Immune System Mouse Models.
The talk about us in the press: LaBiotech

They talk about us in Labiotech – Vaccine/Immunization

Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.

Share this!